Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
- Posted on May 19, 2025
- By CNBC
- 3 Views
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges
